Skip to main content

Articles

Page 5 of 27

  1. Fentanyl has contributed to a sharp rise in the toxicity of the unregulated drug supply and fatal overdoses in Canada. It has also changed injection practices. Injection frequency has increased as a result and...

    Authors: Marilou Gagnon, Katherine Rudzinski, Adrian Guta, Rose A. Schmidt, David T. Kryszajtys, Gillian Kolla and Carol Strike
    Citation: Harm Reduction Journal 2023 20:81
  2. Solitary use of substances is a risk factor for substance use-related mortality. Novel e-health harm reduction interventions such as virtual overdose monitoring services (VOMS) have emerged in North America to...

    Authors: Tyler Marshall, Dylan Viste, Stephanie Jones, Julia Kim, Amanda Lee, Farah Jafri, Oona Krieg and S. Monty Ghosh
    Citation: Harm Reduction Journal 2023 20:80
  3. Research on women who inject drugs is scarce in low- and middle-income countries. Women experience unique harms such as sexism and sexual violence which translate into negative health outcomes. The present wor...

    Authors: Pablo Gonzalez-Nieto, Anabel Salimian, Jaime Arredondo, Lourdes Angulo, Alejandra García de Loera, Said Slim, Steve Shoptaw, Mary C. Cambou, Eileen V. Pitpitan and David Goodman-Meza
    Citation: Harm Reduction Journal 2023 20:79
  4. Despite the dramatic increase in opioid-related deaths in recent years, global access to treatment remains poor. A major barrier to people accessing Medication-assisted treatment of the opioid use disorder (MO...

    Authors: Sonam Prakashini Banka-Cullen, Catherine Comiskey, Peter Kelly, Mary Beth Zeni, Ana Gutierrez and Usha Menon
    Citation: Harm Reduction Journal 2023 20:78
  5. The World Health Organization has set a goal to reach world elimination of hepatitis C virus (HCV) by 2030. Needle and syringe programs (NSP) for people who inject drugs (PWID) are crucial to achieve this goal...

    Authors: E. Kågström, A. Lannergård, J. El Khosht, P. Lörelius, J. Månflod and S. Strömdahl
    Citation: Harm Reduction Journal 2023 20:77
  6. Globally, the rise in the number of people living with a substance use disorder (SUD) carries a multitude of individual and social health implications for carers and their families, often impacting negatively ...

    Authors: Ilze Swanepoel, Gretel Crafford, Stephan Geyer and Tessa S. Marcus
    Citation: Harm Reduction Journal 2023 20:76
  7. Fentanyl and fentanyl-related analogues are the main drivers of overdose death in the USA, particularly among people who inject drugs (PWID). Despite the fact that non-Hispanic whites exhibit higher population...

    Authors: R. Abadie
    Citation: Harm Reduction Journal 2023 20:75
  8. The COVID-19 pandemic particularly affected the health of vulnerable population, such as people who use drugs. Due to compromised baseline health status, certain drug uses and settings and socioeconomic depriv...

    Authors: Nacho Sánchez-Valdivia, Maria Gabriela Barbaglia, Marc Olivella-Cirici, Noelia Girona Marcos, Mercè Gotsens, Amaia Garrido Albaina, Cristina Rius, Montse Bartroli and Gloria Pérez
    Citation: Harm Reduction Journal 2023 20:74
  9. People who inject drugs (PWID) represent a population with an increased prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach the WHO goal of eliminating HCV as a major pub...

    Authors: K. Lindqvist, Z. Thorin and M. Kåberg
    Citation: Harm Reduction Journal 2023 20:72
  10. The COVID-19 pandemic disrupted healthcare and substance use services engagement, including primary and mental health services as well as residential and outpatient drug treatment. Women who inject drugs (WWID...

    Authors: Lyra Cooper, Joseph G. Rosen, Leanne Zhang, Danielle Pelaez, Praise F. Olatunde, Jill Owczarzak, Ju Nyeong Park and Jennifer L. Glick
    Citation: Harm Reduction Journal 2023 20:71
  11. Unprecedented increases in substance-related overdose fatalities have been observed in Texas and the U.S. since the onset of the COVID-19 pandemic and have made clear there is considerable need to reduce harms...

    Authors: Kasey Claborn, Jake Samora, Katie McCormick, Quanisha Whittfield, Frederic Courtois, Kyle Lozada, Daniel Sledge, Annie Burwell, Sandra Chavez, Jamie Bailey, Chris Bailey, Chelsea Dalton Pederson, Claire Zagorski, Lucas Hill, Fiona N. Conway, Lori Holleran Steiker…
    Citation: Harm Reduction Journal 2023 20:70
  12. The opioid overdose crisis in the USA has called for expanding access to evidence-based substance use treatment programs, yet many barriers limit the ability of people who inject drugs (PWID) to engage in thes...

    Authors: Abigail K. Winiker, Kristin E. Schneider, Rebecca Hamilton White, Allison O’Rourke, Suzanne M. Grieb and Sean T. Allen
    Citation: Harm Reduction Journal 2023 20:69
  13. Brass screens are considered an essential part of the safer drug smoking/inhalation supplies and are widely distributed by harm reduction programs in Canada. However, the use of commercially available steel wo...

    Authors: Bradley J. Diak, Miroslav Miskovic, Nadia Zurba and Denise Beaumont
    Citation: Harm Reduction Journal 2023 20:68
  14. Authors: Muhammad Radzi Abu Hassan, Huan-Keat Chan, Mahani Nordin, Ranimah Yahya, Wan Ruzilasalwa Wan Sulaiman, Siti Aminah Akbar Merican, Darisah Lah, Xiaohui Sem and Sonjelle Shilton
    Citation: Harm Reduction Journal 2023 20:67

    The original article was published in Harm Reduction Journal 2023 20:48

  15. Heroin-Assisted Treatment (HAT) is well evidenced internationally to improve health and social outcomes for people dependent on opioids who have not been helped by traditional treatment options. Despite this e...

    Authors: Fleur Riley, Magdalena Harris, Hannah Louise Poulter, Helen J. Moore, Daniel Ahmed, Graham Towl and Tammi Walker
    Citation: Harm Reduction Journal 2023 20:66
  16. Electronic nicotine delivery systems (ENDS), such as the JUUL system, are nicotine products for adults who currently smoke cigarettes but are looking for an alternative to combustible cigarettes. Sales of ENDS...

    Authors: Yingying Xu, Anindya Sen, Tengjiao Chen, Christopher M. Harris and Shivaani Prakash
    Citation: Harm Reduction Journal 2023 20:65
  17. In response to the ongoing opioid epidemic, there have been efforts to develop novel harm reduction strategies alongside scaling of currently implemented programs. Virtual overdose monitoring services (VOMS) a...

    Authors: Fahad Safi, William Rioux, Nathan Rider, Barbara Fornssler, Stephanie Jones and S. Monty Ghosh
    Citation: Harm Reduction Journal 2023 20:64
  18. To examine COVID-19 vaccination and HIV transmission among persons who inject drugs (PWID) during the COVID-19 pandemic (2020–2022) in New York City (NYC).

    Authors: Don C. Des Jarlais, Chenziheng Allen Weng, Jonathan Feelemyer and Courtney McKnight
    Citation: Harm Reduction Journal 2023 20:63
  19. Past research has either focused on alcohol or drug preloading before a night out, but not on the interaction between them. With increased risks of harm through interaction effects, we wished to build upon pre...

    Authors: Lee R. J. Hughes, Corey Allen and Grant J. Devilly
    Citation: Harm Reduction Journal 2023 20:62
  20. The adulteration of the illicit drug supply with fentanyl and its analogues is driving the ongoing overdose crisis in North America. While various harm reduction interventions address overdose-related risks, t...

    Authors: Manal Mansoor, Annie Foreman-Mackey, Andrew Ivsins and Geoff Bardwell
    Citation: Harm Reduction Journal 2023 20:61
  21. Preliminary evidence suggests that people who inject drugs (PWID) may be at an increased risk of developing infective endocarditis (IE), hepatitis C virus (HCV) infection, and/or human immunodeficiency virus (...

    Authors: Andrea C. Tricco, Amanda Parker, Areej Hezam, Vera Nincic, Fatemeh Yazdi, Yonda Lai, Charmalee Harris, Zachary Bouck, Ahmed M. Bayoumi and Sharon E. Straus
    Citation: Harm Reduction Journal 2023 20:60
  22. The injection of morphine from morphine sulfate capsules containing sustained-release microbeads (Skenan®) is a practice frequently described by French intravenous opioid users. They seek an injectable form of...

    Authors: Célian Bertin, Edouard Montigne, Sarah Teixeira, Florent Ferrer, Louis Lauwerie, Damien Richard and Nicolas Authier
    Citation: Harm Reduction Journal 2023 20:59
  23. In the US, stimulant use is associated with a 3–6 times greater rate of HIV seroconversion in sexual minority men (SMM) than in those who do not use stimulants. Annually, 1 in 3 SMM who HIV seroconvert will be...

    Authors: Leah Davis-Ewart, Ji-Young Lee, Michael Viamonte, Josè Colon-Burgos, Audrey Harkness, Mariano Kanamori, Dustin T. Duncan, Susanne Doblecki-Lewis, Adam W. Carrico and Christian Grov
    Citation: Harm Reduction Journal 2023 20:58
  24. Authors: Isabelle Volpe, Rita Brien, Jasmin Grigg, Stephanie Tzanetis, Sione Crawford, Tom Lyons, Nicole Lee, Ginny McKinnon, Caitlin Hughes, Alan Eade and Monica J. Barratt
    Citation: Harm Reduction Journal 2023 20:55

    The original article was published in Harm Reduction Journal 2023 20:3

  25. There are growing concerns about illicitly manufactured fentanyl (IMF) contamination of methamphetamine. This study aims to characterize the lay views and experiences with IMF-contaminated methamphetamine (IMF...

    Authors: Raminta Daniulaityte, Lance Ruhter, Matthew Juhascik and Sydney Silverstein
    Citation: Harm Reduction Journal 2023 20:54
  26. As the overdose crisis in Canada continues to escalate in severity, novel interventions and programs are required. Safer Supply programs offer pharmaceutical-grade medication to people who use drugs to replace...

    Authors: Marlene Haines and Patrick O’Byrne
    Citation: Harm Reduction Journal 2023 20:53
  27. The intention of chemsex-practicing gay and bisexual men and other men who have sex with men (GBMSM) to reduce their drug use is an important factor for the utilization of harm reduction services. This study a...

    Authors: Yu-Ru Hung, Tsan-Tse Chuang, Tsai-Wei Chen, An-Chun Chung, Meng-Tzu Wu, Su-Ting Hsu, Nai-Ying Ko and Carol Strong
    Citation: Harm Reduction Journal 2023 20:52
  28. Since the onset of the COVID-19 pandemic, overdose rates in North America have continued to rise, with more than 100,000 drug poisoning deaths in the past year. Amidst an increasingly toxic drug supply, the pa...

    Authors: Kaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, Kurt Lock, Adam Easterbrook, Scott MacDonald, Scott Harrison, Julie Lajeunesse, David Byres, Martin Schechter and Eugenia Oviedo-Joekes
    Citation: Harm Reduction Journal 2023 20:51
  29. People who inject drugs (PWID) and prisoners are considered key populations at risk for human immunodeficiency virus (HIV) and/or Hepatitis C Virus (HCV). In 2016, the Joint United Nations Program on HIV/AIDS ...

    Authors: H. Stöver, A. Dichtl, D. Schäffer and M. Grabski
    Citation: Harm Reduction Journal 2023 20:50
  30. Harm reduction services that employ or are operated by people who use drugs are an effective means of mitigating overdose risks and other drug-related harms. However, stereotypes portraying people who use crim...

    Authors: Tamar Austin, Jennifer Lavalley, Sylvia Parusel, Alexandra B. Collins, Michelle Olding and Jade Boyd
    Citation: Harm Reduction Journal 2023 20:49
  31. Despite advancements in hepatitis C virus (HCV) treatment, low uptake among hard-to-reach populations remains a global issue. The current study aimed to assess the feasibility of a modified same-day test-and-t...

    Authors: Muhammad Radzi Abu Hassan, Huan-Keat Chan, Mahani Nordin, Ranimah Yahya, Wan Ruzilasalwa Wan Sulaiman, Siti Aminah Akbar Merican, Darisah Lah, Xiaohui Sem and Sonjelle Shilton
    Citation: Harm Reduction Journal 2023 20:48

    The Correction to this article has been published in Harm Reduction Journal 2023 20:67

  32. People with Opioid Use Disorder (PWOUD) represent an underserved and marginalized population for whom treatment gaps exist. Low-barrier programs like mobile care units and street outreach programs have yielded...

    Authors: Richard Gadomski, Snehal Bhatt, Jessica Gross, Juan Antonio Dixon, Phillip Fiuty, Max Shapiro, Rafael Fernandez-Mancha and Julie Salvador
    Citation: Harm Reduction Journal 2023 20:47
  33. Drug-related deaths in Scotland are the highest in Europe. Half of all deaths in people experiencing homelessness are drug related, yet we know little about the unmet health needs of people experiencing homele...

    Authors: Richard Lowrie, Andrew McPherson, Frances S. Mair, Kate Stock, Caitlin Jones, Donogh Maguire, Vibhu Paudyal, Clare Duncan, Becky Blair, Cian Lombard, Steven Ross, Fiona Hughes, Jane Moir, Ailsa Scott, Frank Reilly, Laura Sills…
    Citation: Harm Reduction Journal 2023 20:46
  34. Evidence on the social determinants of mental health conditions and violence among people who inject or use drugs (PWUD) is limited, particularly in conflict-affected countries. We estimated the prevalence of ...

    Authors: Khine Wut Yee Kyaw, Lucy Platt, Murdo Bijl, Sujit D. Rathod, Aung Yu Naing and Bayard Roberts
    Citation: Harm Reduction Journal 2023 20:45
  35. Illicit substance use has constantly evolved over the years, particularly in the party scene. Monitoring these changes is essential to adapt harm reduction strategies. The OCTOPUS survey was implemented to enh...

    Authors: Marion Istvan, Vincent Bresdin, Marie Mainguy, Pauline Laigo, Marie Grall-Bronnec, Vincent Eudeline, Jean-Emmanuel Guillet, Manon Guillo, Laurent Babonnaud, Pascale Jolliet, Benoit Schreck and Caroline Victorri-Vigneau
    Citation: Harm Reduction Journal 2023 20:43
  36. A precipitous decline in health status among people recently released from prison is common. In Victoria, Australia, opioid agonist treatment (OAT) in the community involves frequent contact with primary care,...

    Authors: Michael Curtis, Anna L. Wilkinson, Paul Dietze, Ashleigh C. Stewart, Stuart A. Kinner, Rebecca J. Winter, Campbell Aitken, Shelley J. Walker, Reece D. Cossar, Tony Butler and Mark Stoové
    Citation: Harm Reduction Journal 2023 20:42
  37. Opioid-involved overdose continues to rise, largely explained by fentanyl adulteration of the illicit opioid supply. Fentanyl test strips are a novel drug checking tool that can be used by people who use drugs...

    Authors: Alyssa Shell Tilhou, Jen Zaborek, Amelia Baltes, Elizabeth Salisbury-Afshar, Julia Malicki and Randall Brown
    Citation: Harm Reduction Journal 2023 20:41
  38. Opioids were implicated in approximately 88,000 fatal overdoses (OD) globally. However, in principle all opioid OD are reversible with the timely administration of naloxone hydrochloride. Despite the widesprea...

    Authors: Josh Dumbrell, Hadi Daneshvar, Alberto Oteo, Alexander Baldacchino and Catriona Matheson
    Citation: Harm Reduction Journal 2023 20:40
  39. Drug checking is increasingly being explored outside of festivals and events to be an ongoing service within communities, frequently integrated within responses to illicit drug overdose. The choice of instrume...

    Authors: Lea Gozdzialski, Bruce Wallace and Dennis Hore
    Citation: Harm Reduction Journal 2023 20:39
  40. Since the emergence of fentanyl in the drug market, syringe services programs (SSPs) have been at the forefront of providing life-saving tools such as naloxone and fentanyl test strips to people who use drugs ...

    Authors: Nisha Beharie, Adelya Urmanche and Alex Harocopos
    Citation: Harm Reduction Journal 2023 20:38
  41. Distribution of naloxone and training on its proper use are evidence-based strategies for preventing opioid overdose deaths. In-person naloxone training was conducted in major metropolitan areas and urban cent...

    Authors: Charles W. Mathias, Diana M. Cavazos, Kelly McGlothen-Bell, Allison D. Crawford, Brieanna Flowers-Joseph, Zhan Wang and Lisa M. Cleveland
    Citation: Harm Reduction Journal 2023 20:37
  42. Persons who inject drugs (PWID) commonly experience venous degradation as a complication of prolonged injection, which makes routine phlebotomy difficult. Clients may decline care due to the perceived lack of ...

    Authors: Michael Huyck, Stockton Mayer, Sarah Messmer, Charles Yingling and Shirley Stephenson
    Citation: Harm Reduction Journal 2023 20:36
  43. The objective of this study was to examine international literature to identify best practices for treatment of opioid dependence in Indigenous contexts.

    Authors: Rita Henderson, Ashley McInnes, Ava Danyluk, Iskotoah’ka Wadsworth, Bonnie Healy and Lindsay Crowshoe
    Citation: Harm Reduction Journal 2023 20:34
  44. Community-based harm reduction vending machines (HRVM) are not new to the field of public health; numerous countries have implemented them in response to the needs of people who use drugs over the last three d...

    Authors: Erin Russell, Jessica Johnson, Zach Kosinski, Callie Kaplan, Nicole Barnes, Sean Allen and Emily Haroz
    Citation: Harm Reduction Journal 2023 20:33
  45. The COVID-19 pandemic worsened the ongoing overdose crisis in the United States (US) and caused significant mental health strain and burnout among health care workers (HCW). Harm reduction, overdose prevention...

    Authors: Ijeoma C. Unachukwu, Matthew P. Abrams, Abby Dolan, Kehinde Oyekemi, Zachary F. Meisel, Eugenia C. South and Shoshana V. Aronowitz
    Citation: Harm Reduction Journal 2023 20:32